Caption Management, LLC Allakos Inc. Put Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$1.72 - $3.18 $14,792 - $27,348	8,600 New	8,600 $23,000
Q1 2022 May 13, 2022	SELL	$5.08 - $9.81 $203,200 - $392,400	-40,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$8.55 - $111.89 $372,780 - $4.88 Million	-43,600 Reduced 52.15%	40,000 $392,000
Q3 2021 Nov 12, 2021	BUY	$76.53 - $110.43 $4.1 Million - $5.92 Million	53,600 Added 178.67%	83,600 $8.85 Million
Q3 2020 Nov 16, 2020	BUY	$66.43 - $90.99 $1.99 Million - $2.73 Million	30,000 New	30,000 $2.44 Million
Q1 2020 May 15, 2020	SELL	$44.49 - $93.39 $444,900 - $933,900	-10,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$66.49 - $137.73 $664,900 - $1.38 Million	10,000 New	10,000 $954,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $79.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.